問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2019-11-30 - 2026-09-30
Condition/Disease
xxxxxx
Test Drug
Participate Sites9Sites
Recruiting9Sites
2023-05-01 - 2028-10-31
Participate Sites8Sites
Not yet recruiting3Sites
Recruiting5Sites
2023-10-13 - 2029-12-31
Participate Sites5Sites
2021-08-01 - 2025-01-24
Participate Sites6Sites
Recruiting2Sites
Terminated1Sites
2022-01-12 - 2027-12-31
Not yet recruiting5Sites
2023-10-02 - 2028-01-05
Participate Sites10Sites
Recruiting10Sites
2023-10-16 - 2027-09-09
2025-06-01 - 2034-08-15
Participate Sites4Sites
Recruiting4Sites
2020-04-01 - 2025-11-26
Previously Untreated, Locally Advanced Non-small Cell Lung Cancer
OPDIVO (nivolumab) Injection 10mg/mL OPDIVO (nivolumab) Injection 10mg/mL YERVOY (ipilimumab) Injection 5mg/mL YERVOY (ipilimumab) Injection 5mg/mL
Participate Sites7Sites
Not yet recruiting1Sites
Recruiting6Sites
2004-04-01 - 2006-12-01
Terminated4Sites
全部
